Novelix Pharmaceuticals Financials
BSE: 536565
₹76.55
₹-2.95
(-3.71%)
As on 04-Sep-2026IST
Market cap
₹218 Cr
Revenue (TTM)
₹147 Cr
P/E Ratio
60
P/B Ratio
3.4
Div. Yield
0 %
loading...
Income Statement (₹ Cr) |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
146.87
|
30.72
|
4.22
|
1.40
|
0.84
|
1.01
|
|
|
|
|
|
|
Total Income
|
146.90
|
30.73
|
4.53
|
1.92
|
1.39
|
1.33
|
|
|
|
|
|
|
Total Expenditure
|
142.28
|
30.57
|
4.47
|
1.92
|
2.89
|
4.52
|
|
|
|
|
|
|
EBITDA
|
4.59
|
0.15
|
-0.25
|
-0.52
|
-2.05
|
-3.51
|
|
|
|
|
|
|
Depreciation
|
0.16
|
0.04
|
0.04
|
0.06
|
0.07
|
0.08
|
|
|
|
|
|
|
EBIT
|
4.43
|
0.11
|
-0.28
|
-0.57
|
-2.12
|
-3.59
|
|
|
|
|
|
|
Interest
|
0.12
|
0.00
|
0.00
|
0.00
|
0.00
|
0.00
|
|
|
|
|
|
|
Other Income
|
0.03
|
0.02
|
0.31
|
0.52
|
0.55
|
0.32
|
|
|
|
|
|
|
Exceptional Items
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Profit before Tax
|
4.35
|
0.12
|
0.02
|
-0.06
|
-1.57
|
-3.27
|
|
|
|
|
|
|
Provision for Tax
|
0.72
|
0.04
|
0.01
|
0.00
|
-0.01
|
0.00
|
|
|
|
|
|
|
Profit after Tax
|
3.63
|
0.08
|
0.01
|
-0.06
|
-1.56
|
-3.27
|
|
|
|
|
|
Liabilities (₹ Cr) |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
46.49
|
17.54
|
7.35
|
7.20
|
7.24
|
8.80
|
|
|
|
|
|
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Non-Current Liabilities
|
4.32
|
-0.04
|
-0.05
|
-0.06
|
-0.07
|
-0.06
|
|
|
|
|
|
|
Current Liabilities
|
41.61
|
9.67
|
0.01
|
0.06
|
0.01
|
0.02
|
|
|
|
|
|
|
Total Liabilities
|
92.42
|
27.21
|
7.36
|
7.26
|
7.25
|
8.83
|
|
|
|
|
|
Assets (₹ Cr) |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
3.51
|
0.23
|
3.18
|
2.95
|
2.55
|
4.07
|
|
|
|
|
|
|
Current Assets
|
88.91
|
26.93
|
4.13
|
4.24
|
4.63
|
4.70
|
|
|
|
|
|
|
Total Assets
|
92.42
|
27.21
|
7.36
|
7.26
|
7.25
|
8.83
|
|
|
|
|
|
|
Total Debt*
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Net Current Assets
|
47.30
|
17.27
|
4.12
|
4.18
|
4.62
|
4.68
|
|
|
|
|
|
|
Contingent Liabilities
|
--
|
--
|
--
|
--
|
--
|
0.03
|
|
|
|
|
|
Cashflow (₹ Cr) |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
-13.68
|
-0.34
|
-2.41
|
0.59
|
0.58
|
|
|
|
|
|
|
Cash Flow from Investing Activities
|
--
|
2.93
|
0.19
|
0.08
|
0.28
|
0.21
|
|
|
|
|
|
|
Cash from Financing Activities
|
--
|
11.32
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Net Cash Inflow / Outflow
|
--
|
0.56
|
-0.16
|
-2.33
|
0.87
|
0.78
|
|
|
|
|
|
Financials Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
1.88
|
0.08
|
0.01
|
-0.07
|
-1.93
|
-4.04
|
|
|
|
|
|
|
Cash EPS (₹)
|
1.28
|
0.12
|
0.06
|
0.00
|
-1.84
|
-3.93
|
|
|
|
|
|
|
Adjusted Book Value (₹)
|
22.30
|
17.63
|
9.08
|
8.88
|
8.94
|
10.87
|
|
|
|
|
|
|
Dividend per Share (₹)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Cash Flow per Share (₹)
|
--
|
-13.75
|
-0.42
|
-2.97
|
0.73
|
0.71
|
|
|
|
|
|
|
Free Cash Flow per Share (₹)
|
--
|
-13.88
|
-0.06
|
-2.34
|
-2.76
|
1.12
|
|
|
|
|
|
Profitability Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
1.00
|
0.31
|
-0.81
|
-19.51
|
-31.33
|
|
|
|
|
|
|
ROE (%)
|
10.07
|
0.68
|
0.14
|
-0.83
|
-19.45
|
-31.32
|
|
|
|
|
|
|
ROA (%)
|
6.07
|
0.49
|
0.14
|
-0.83
|
-19.56
|
-31.42
|
|
|
|
|
|
|
EBIT Margin (%)
|
3.02
|
0.35
|
-6.74
|
-40.86
|
-251.12
|
-356.99
|
|
|
|
|
|
|
Net Margin (%)
|
2.47
|
0.28
|
0.23
|
-3.12
|
-111.86
|
-245.62
|
|
|
|
|
|
|
Cash Profit Margin (%)
|
0.00
|
0.40
|
1.15
|
-0.26
|
-176.55
|
-316.25
|
|
|
|
|
|
Growth Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
179.92
|
627.27
|
200.72
|
66.58
|
-16.25
|
-2.47
|
|
|
|
|
|
|
EBIT Growth (%)
|
513.99
|
137.93
|
50.37
|
72.89
|
41.09
|
-882.41
|
|
|
|
|
|
|
Net Profit Growth (%)
|
537.96
|
711.76
|
117.37
|
96.16
|
52.27
|
-3,546.25
|
|
|
|
|
|
|
EPS Growth (%)
|
268.47
|
558.14
|
117.43
|
96.16
|
52.26
|
-3,546.11
|
|
|
|
|
|
|
Book Value Growth (%)
|
--
|
138.48
|
2.22
|
-0.66
|
-17.72
|
-27.07
|
|
|
|
|
|
Valuation Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
60.04
|
313.43
|
1,332.56
|
--
|
--
|
--
|
|
|
|
|
|
|
Price / Book Value
|
3.43
|
1.51
|
1.89
|
1.01
|
0.99
|
0.62
|
|
|
|
|
|
|
Dividend Yield (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
EV/EBITDA
|
47.41
|
159.27
|
227.43
|
-3,528.80
|
-3.08
|
-1.17
|
|
|
|
|
|
|
Close Price (₹)
|
76.85
|
26.61
|
17.19
|
9.00
|
8.89
|
6.76
|
|
|
|
|
|
|
High Price (₹)
|
92.00
|
26.61
|
17.19
|
11.10
|
10.83
|
7.10
|
|
|
|
|
|
|
Low Price (₹)
|
37.71
|
17.19
|
8.00
|
7.08
|
5.28
|
1.89
|
|
|
|
|
|
|
Market Cap (₹ Cr)
|
217.94
|
26.48
|
13.92
|
7.29
|
7.20
|
5.48
|
|
|
|
|
|
Solvency Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
0.09
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Short term debt to equity ratio
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Current Ratio
|
2.14
|
2.79
|
407.44
|
68.83
|
568.35
|
194.19
|
|
|
|
|
|
|
Quick Ratio
|
1.79
|
2.70
|
289.60
|
55.52
|
503.09
|
183.93
|
|
|
|
|
|
|
Interest Coverage
|
38.83
|
192.23
|
17.35
|
-215.58
|
--
|
-4,671.71
|
|
|
|
|
|
Operating Efficiency Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
40.15
|
59.04
|
0.32
|
13.56
|
11.84
|
8.44
|
|
|
|
|
|
|
Asset Turnover
|
2.46
|
1.78
|
0.58
|
0.20
|
0.11
|
0.10
|
|
|
|
|
|
|
Receivable days
|
--
|
107.83
|
8.81
|
37.71
|
40.00
|
29.83
|
|
|
|
|
|
|
Inventory Days
|
--
|
12.11
|
87.06
|
175.73
|
168.85
|
59.18
|
|
|
|
|
|
|
Payable days
|
--
|
57.42
|
2.70
|
14.52
|
--
|
3.78
|
|
|
|
|
|
|
Cash Conversion Cycle
|
--
|
62.52
|
93.17
|
198.92
|
--
|
85.23
|
|
|
|
|
|
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
